GO
Loading...

Stop Trading!

Even though Wal-Mart shares are continuing to move higher, you can still get in now, Cramer said today on Stop Trading! But he isn’t a fan of the retailer's plan to spin off Sam’s Club. There’s no reason for Sam’s Club to IPO, he said, because it’s a “good adjunct” to the rest of Wal-Mart.

Cramer also said Celgene was “a great buy here.” At the American Society of Clinical Oncology Conference in Chicago this weekend, Celgene made a “major statement” about its cancer drug, Revlimid, which “just got ignored.” The stock has been on a tear for the past year, but Cramer thinks Revlimid gives it even more room for upside.

And Cramer said a Bear Stearns analyst upgrade of Sirius is a “big call.” Even though the stock is down today, Cramer said it has the chance to hit the analyst's $4 price target. Cramer has been bearish on both Sirius and XM Satellite Radio for a while, saying he thinks the only chance either company has of surviving is if they get clearance to merge.


Questions? Comments? madmoney@cnbc.com

Symbol
Price
 
Change
%Change
CELG
---
SIRI
---
WMT
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.